Anzeige
Mehr »
Samstag, 06.09.2025 - Börsentäglich über 12.000 News
SuperBuzz x Prymatica: Ein Vertriebsdeal, der KI-Hype in B2B-Umsätze verwandeln könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
207 Leser
Artikel bewerten:
(1)

Loftware, Inc.: Loftware Prisym 360 Version 1.16 Strengthens 'All-In-One' Clinical Trials Labeling Solution with New Features to Deliver Efficiencies and Simplify Compliance

Release Incorporates Clinical Data Connector and Randomization Module to Support End-To-End Management of Streamlined Clinical Labeling Processes

PORTSMOUTH, N.H., Oct. 26, 2022 /PRNewswire/ -- Loftware, the global leader in Enterprise Labeling and Artwork Management solutions, today announced the availability of Loftware Prisym 360 1.16. The latest release of Loftware's cloud-based clinical trials label and content management solution adds two new features designed to increase the efficiency of clinical trial supplies operations while reducing risk and simplifying compliance.

New Loftware logo

Prisym 360 1.16 introduces a new Clinical Data Connector, which streamlines the end-to-end clinical labeling process by connecting clinical supplies applications to Prisym 360's label and booklet design features. This removes the need for any label data to be input manually, helping to automate the process of GxP-compliant label printing and saving valuable user time while reducing the risks associated with manual inputs.

Supporting widely used industry protocols and standards, such as Web Services, SOAP, and REST, to maximize its compatibility with a customer's existing clinical supplies management applications, the Clinical Data Connector allows for the creation and revision of clinical trial master label data within Prisym 360. Consequently, a customer's existing clinical supplies application gains the ability to send print requests and associated data to Prisym 360 to produce labels on demand.

Additionally, Prisym 360 1.16 introduces a Randomization Module, which provides a comprehensive set of clinical label randomization functions that are fully integrated and available through a simple and intuitive user interface. Providing randomization functionality, especially valuable to organizations or teams without access to a RTSM application, the module has been designed in close collaboration with clinical supplies teams within several leading pharmaceutical R&D organizations and clinical supplies service providers. Through a step-by-step process, users can create randomization definitions to generate data for clinical trials packs while remaining fully integrated and compatible with Prisym 360's other clinical trials labeling functions, including the Clinical Data Connector and the 3-Step Clinical Label Print Process.

Both new features have been developed with direct input from existing users and are designed to support industry best practice. Due to the modular nature of Prisym 360, customers can flexibly upgrade their solution to access this new functionality if desired.

Simon Jones, Loftware VP Product Management, Life Sciences, said: "The pressure to reduce trial start-up times coupled with the growth in adaptive clinical trials has prompted focus amongst clinical supplies software application vendors to help streamline the end-to-end clinical trial supplies process. The Prisym 360 Clinical Data Connector, developed with input from best-of-breed Clinical Supplies Management vendors, such as Signant Health, helps simplify inter-connection with Prisym 360, thereby removing the need for manual data entry.

"Similarly, the new Randomization Module is designed to simplify the process of performing patient and kit-based randomization, as being integral within Prisym 360 aids with ease of use whilst helping customers ensure GxP compliance."

The Prisym 360 Clinical Data Connector and Data Randomization modules are now available as part of the latest 1.16 product release of Prisym 360. For more information, visit www.loftware.com

About Loftware:

Loftware?is the world's largest cloud-based Enterprise Labeling and Artwork Management provider, offering an end-to-end labeling solution platform for companies of all sizes. Maintaining a global presence with offices in the US, UK, Germany, Slovenia, China, and Singapore, Loftware boasts over 35 years of expertise in solving labeling challenges. We help companies improve accuracy, traceability and compliance while improving the quality, speed, and efficiency of their labeling. As the leading global provider of Enterprise Labeling and Artwork Management, along with Clinical Trials Labeling and Content Management, Loftware enables supply chain agility, supports evolving regulations, and optimizes business operations for a wide range of?industries. These include automotive, chemicals, consumer products, electronics, food & beverage, manufacturing, medical device, pharmaceuticals, retail and apparel.

Media contacts:
Laura Hindley, Senior PR & Communications Manager, lhindley@loftware.com

Logo - https://mma.prnewswire.com/media/1658239/Loftware_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/loftware-prisym-360-version-1-16-strengthens-all-in-one-clinical-trials-labeling-solution-with-new-features-to-deliver-efficiencies-and-simplify-compliance-301657275.html

© 2022 PR Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.